Skip to main content

Advertisement

SpringerLink
Log in

Acute and prophylactic treatments for migraine: present and future

  • Key Note Lecture
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Herein I will present general principles of acute-care and preventive therapy of migraine, both in the present and the future. Details of currently used migraine acute-care therapies with their contraindications, drug-drug interactions and adverse events will be presented. Details of migraine preventive therapies with their adverse events and drug-drug interactions will be discussed. Some over-the-counter vitamins, minerals and herbs, used as preventive therapy in migraine, will be discussed. Future treatments in the pipeline will be briefly detailed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cady RK (2001) Treatment strategies for migraine headache. JAMA 285:1014–1015

    Article  PubMed  CAS  Google Scholar 

  2. Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine — current understanding and treatment. N Engl J Med 346:257–270

    Article  PubMed  CAS  Google Scholar 

  3. Matchar DB, Young WB, Rosenberg JH et al (2000) Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks. www.neurology.org. April

  4. Mathew NT, Kailasam J, Fischer A (2001) Early intervention using rofecoxib alone, rizatriptan alone and combination of rizatriptan and rofecoxib in acute migraine. Cephalalgia 21:405–432

    Article  Google Scholar 

  5. Hawkey CJ (1999) COX-2 inhibitors. Lancet 353:307–314

    Article  PubMed  CAS  Google Scholar 

  6. Krymchantowski AV, Barbosa JS (2002) Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study. Cephalalgia 22:309–312

    Article  PubMed  CAS  Google Scholar 

  7. Klapper J, Stanton J (1991) The emergency treatment of acute migraine headache; a comparison of intravenous dihydroergota-mine, dexamethasone, and placebo. Cephalalgia 11[Suppl 11]:159–160

    Google Scholar 

  8. Rapoport AM, Tepper SJ (2001) Triptans are all different. Arch Neurol 58:1479–1480

    Article  PubMed  CAS  Google Scholar 

  9. Longmore J, Razzaque Z, Shaw D et al (1998) Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors. Br J Clin Pharmacol 46:577–582

    Article  PubMed  CAS  Google Scholar 

  10. Kuzybski W (1992) Metamizole and hydrocortisone for the interruption of a migraine attack — preliminary study. Headache Q 3:326–328

    Google Scholar 

  11. Ramadan NM, Silberstein SD, Freitag FG et al (2000) Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine. www.neurology.org. April

  12. Weber RB, Reinmuth OM (1971) The treatment of migraine with propranolol. Neurology 21:404–405

    Google Scholar 

  13. Reveiz-Herault L, Cardona AF, Ospina EG, Carrillo P (2003) [Effectiveness of flunarizine in the prophylaxis of migraine: a meta-analytical review of the literature]. Rev Neurol 36:907–912. Review, in Spanish

    PubMed  CAS  Google Scholar 

  14. Silberstein SD (2001) Migraine: preventive treatment. Curr Med Res Opin 17[Suppl 1]:s87–s93

    Article  PubMed  Google Scholar 

  15. Tomkins GE, Jackson JL, O’Malley PG et al (2001) Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med 111:54–63

    Article  PubMed  CAS  Google Scholar 

  16. Saper JR, Silberstein SD, Lake AE et al (1995) Fluoxetine and migraine: comparison of double-blind trials. Headache 35:233

    Article  PubMed  CAS  Google Scholar 

  17. Mathew N, Saper J, Silberstein S et al (1995) Migraine prophylaxis with divalproex. Arch Neurol 52:281–286

    PubMed  CAS  Google Scholar 

  18. Edwards KR, Potter DL, Wu SC et al (2003) Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials. CNS Spectr 8:428–432

    PubMed  Google Scholar 

  19. Mathew NT, Rapoport A, Saper J et al (2001) Efficacy of gabapentin in migraine prophylaxis. Headache 41:119–128

    Article  PubMed  CAS  Google Scholar 

  20. Steiner TJ, Findley LJ, Yuen AW (1997) Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 17:109–112

    Article  PubMed  CAS  Google Scholar 

  21. D’Andrea G, Granella F, Cadaldini M, Manzoni GC (1999) Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. Cephalalgia 19:64–66

    Article  PubMed  CAS  Google Scholar 

  22. Drake ME, Greathouse NI, Armentbright AD, Renner JB (2001) Preventive treatment of migraine with zonisamide. Cephalalgia 21:374

    Google Scholar 

  23. Krusz JC (2001) Levetiracetam as prophylaxis for resistant headaches. Cephalalgia 21:373

    Google Scholar 

  24. Sharma S, Jacobs HS (1997) Polycystic ovary syndrome associated with treatment with the anticonvulsant sodium valproate. Curr Opin Obstet Gynecol 9:391–392

    PubMed  CAS  Google Scholar 

  25. Muller R, Weller P, Chemaissani A (1991) Pleural fibrosis as a side effect of years-long methysergide therapy. Dtsch Med Wochenschr 116:1433–1436

    Article  PubMed  CAS  Google Scholar 

  26. Peatfield R (1986) Drugs acting by modification os serotonin function. Headache 26:129–131

    Google Scholar 

  27. Haria M, Balfour JA (1997) Levetiracetam. CNS Drugs 7:159–164

    Article  CAS  Google Scholar 

  28. Bigal ME, Krymchantowski AV, Rapoport AM (2003) New developments in migraine prophylaxis. Expert Opin Pharmacother 4:433–443. Review

    Article  PubMed  CAS  Google Scholar 

  29. Tronvik E, Stovner LJ, Helde G et al (2003) Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 289:65–69

    Article  PubMed  CAS  Google Scholar 

  30. Silberstein S, Mathew N, Saper J, Jenkins S (2000) Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache 40:445–450

    Article  PubMed  CAS  Google Scholar 

  31. Wang SJ, Fuh JL, Lu SR et al (2003) Migraine prevalence during menopausal transition. Headache 43:470–478

    Article  PubMed  Google Scholar 

  32. Lipton RB, Gobel H, Wilks K, Mauskop A (2002) Efficacy of petasites (an extract from petasites rhizone) 50 and 75 mg for prophylaxis of migraine: results of a randomized, double-blind, placebo-controlled study. Neurology 58[Suppl 3]:A472

    Google Scholar 

  33. Altura BM, Altura BT (1978) Magnesium and vascular tone and reactivity. Blood Vessels 15:5–16

    PubMed  CAS  Google Scholar 

  34. Welch KM, Ramadan NM (1995) Mitochondria, magnesium and migraine. J Neurol Sci 134:9–14

    Article  PubMed  CAS  Google Scholar 

  35. Schoenen J, Jacquy J, Lenaerts M (1998) Effectiveness of highdose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 50:466–470

    PubMed  CAS  Google Scholar 

  36. Sandor PS, Clemente LD, Coppola G et al (2005) Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlle trial. Neurology 64:713–715

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

    Alan M. Rapoport

  2. The New England Center for Headache, Stamford, CT, USA

    Alan M. Rapoport

  3. 239 South Orange Drive, Los Angeles, CA, 90036, USA

    Alan M. Rapoport

Authors
  1. Alan M. Rapoport
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alan M. Rapoport.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rapoport, A.M. Acute and prophylactic treatments for migraine: present and future. Neurol Sci 29 (Suppl 1), 110–122 (2008). https://doi.org/10.1007/s10072-008-0901-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-008-0901-x

Keywords

Search

Navigation